Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants with Type 1 Diabetes and Obesity or Overweigh

Project: Research

Project Details

StatusActive
Effective start/end date04/2/2504/15/27

Funding

  • Lilly USA LLC: $122,003.00